Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zeitschrift fur Gastroenterologie·2024
Same author

Zeitschrift fur Gastroenterologie·2023
Same author

[Not Available].

Der Internist·2016
Same author

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

Revista de gastroenterologia de Mexico·2015
Same author

[Azathioprine in Crohn's disease therapy--guidance against the background of recent studies].

Zeitschrift fur Gastroenterologie·2014
Same author

[Therapy of chronic inflammatory bowel diseases. Standards, controversies and perspectives].

Der Internist·2014

Related Experiment Videos

[Classification and management of upper gastrointestinal bleeding].

K Herrlinger1

  • 1Abteilung für Gastroenterologie, Hepatologie und Endokrinologie, Robert-Bosch-Krankenhaus, Auerbachstraße 110, 70376 Stuttgart, Deutschland. klaus.herrlinger@rbk.de

Der Internist
|August 4, 2010
PubMed
Summary

Upper gastrointestinal bleeding is a common emergency. This review covers modern treatments for variceal and non-variceal bleeding, focusing on success rates and complications.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Upper gastrointestinal bleeding (UGIB) is a frequent medical emergency.
  • Distinguishing between variceal and non-variceal causes is critical for treatment.
  • Risk assessment guides endoscopic timing and prognosis.

Purpose of the Study:

  • To review modern therapeutic techniques for UGIB.
  • To compare success rates and complications of different interventions.
  • To provide an overview for clinicians managing UGIB.

Main Methods:

  • Literature review of current therapeutic strategies for UGIB.
  • Analysis of data on endoscopic interventions.
  • Synthesis of information on variceal and non-variceal bleeding management.

Main Results:

  • Various endoscopic techniques exist for UGIB.
  • Treatment success varies based on bleeding type and intervention.
  • Potential complications are associated with all therapeutic approaches.

Conclusions:

  • Effective management of UGIB requires accurate diagnosis and risk stratification.
  • Modern therapies offer improved outcomes but carry risks.
  • Continued evaluation of therapeutic interventions is necessary.